trial

Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia

NCTId NCT03148639
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 19 (actual)
Sponsored by Ciusss de L'Est de l'Île de Montréal
Primary completion 2017-03-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
19 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2015-09-01
Primary completion
2017-03-31
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Avatar therapyTreatment-as-usual

Sponsors

Ciusss de L'Est de l'Île de MontréalLead Sponsor
Centre de Recherche de l'Institut Universitaire en santé Mentale de MontréalCollaborator

Investigators

1
Alexandre Dumais, MD, Ph.DPrincipal Investigator

Sites

1 total
Montreal, Canada

Facts & assertions

4 sourced
Enrollment
19
Phase
NA
Primary Completion Date
2017-03-31
Status
COMPLETED
relationships
The graph out of here
drug
Avatar therapy
drug
Treatment-as-usual
drug
lead_sponsor
Ciusss de L'Est de l'Île de Montréal
company
collaborator
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
company
indication
Hallucinations
indication
Treatment-resistant Schizophrenia
indication
Auditory Hallucination, Verbal
indication
investigator
Alexandre Dumais, MD, Ph.D
person